NM_000256.3:c.1789C>T

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM5PP3_Strong

The NM_000256.3(MYBPC3):​c.1789C>T​(p.Arg597Trp) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000034 in 1,558,666 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R597Q) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000032 ( 0 hom. )

Consequence

MYBPC3
NM_000256.3 missense, splice_region

Scores

9
10
1
Splicing: ADA: 0.1545
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:11

Conservation

PhyloP100: 3.70

Publications

6 publications found
Variant links:
Genes affected
MYBPC3 (HGNC:7551): (myosin binding protein C3) MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3 is expressed exclusively in heart muscle and is a key regulator of cardiac contraction. Mutations in this gene are a frequent cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, May 2022]
MYBPC3 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 4
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • left ventricular noncompaction 10
    Inheritance: AR, AD Classification: DEFINITIVE, MODERATE, LIMITED Submitted by: Ambry Genetics
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • atrial fibrillation
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-47341991-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 164098.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.962

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYBPC3NM_000256.3 linkc.1789C>T p.Arg597Trp missense_variant, splice_region_variant Exon 18 of 35 ENST00000545968.6 NP_000247.2 Q14896-1A5YM48

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYBPC3ENST00000545968.6 linkc.1789C>T p.Arg597Trp missense_variant, splice_region_variant Exon 18 of 35 5 NM_000256.3 ENSP00000442795.1 Q14896-1
MYBPC3ENST00000399249.6 linkc.1789C>T p.Arg597Trp missense_variant, splice_region_variant Exon 17 of 34 5 ENSP00000382193.2 A8MXZ9
MYBPC3ENST00000544791.1 linkn.1789C>T splice_region_variant, non_coding_transcript_exon_variant Exon 18 of 27 5 ENSP00000444259.1 F5GZR4

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152018
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000297
AC:
5
AN:
168412
AF XY:
0.0000562
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000396
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000591
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000320
AC:
45
AN:
1406648
Hom.:
0
Cov.:
32
AF XY:
0.0000317
AC XY:
22
AN XY:
694438
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32024
American (AMR)
AF:
0.0000554
AC:
2
AN:
36088
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25276
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36328
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79918
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50174
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5708
European-Non Finnish (NFE)
AF:
0.0000388
AC:
42
AN:
1082660
Other (OTH)
AF:
0.0000171
AC:
1
AN:
58472
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000526
AC:
8
AN:
152018
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74234
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41392
American (AMR)
AF:
0.00
AC:
0
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68002
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000815
Hom.:
0
Bravo
AF:
0.0000453
ExAC
AF:
0.0000340
AC:
4
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:11
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:6
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 09, 2021
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

proposed classification - variant undergoing re-assessment, contact laboratory -

Jun 28, 2021
AiLife Diagnostics, AiLife Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 27, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified in unrelated patients with HCM and ARVC in published literature as well as in patients with HCM, LVNC, or DCM referred for genetic testing at GeneDx, although at least one individual harbored an additional variant that likely contributed to disease (PMID: 35208637, 36788754, 37652022, 25524337, 27532257, 33782553, Serio A et al., European Society of Cardiology Working Group. Myocardial and Pericardial diseases Newsletter; March, 2009); Identified in a pediatric patient with HCM who also harbored a pathogenic variant in the MYBPC3 gene in trans (PMID: 30896616); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25524337, 28679633, 33258288, 33782553, 35208637, 36788754, 37652022, 27532257, 30896616) -

Feb 24, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypertrophic cardiomyopathy Pathogenic:1Uncertain:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 597 of the MYBPC3 protein (p.Arg597Trp). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with hypertrophic cardiomyopathy (PMID: 25524337, 27532257, 30896616, 33782553, 36788754, 37652022). ClinVar contains an entry for this variant (Variation ID: 179549). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

Apr 10, 2024
All of Us Research Program, National Institutes of Health
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This missense variant replaces arginine with tryptophan at codon 597 of the MYBPC3 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant.This variant has been reported in two unrelated individuals affected with hypertrophic cardiomyopathy (HCM) (PMID: 25524337, 27532257). This variant has been reported in another individual affected with HCM, who also carried a pathogenic truncation variant in the same gene (PMID: 30896616). Additionally, this variant has been reported in three related individuals from an Italian family affected with HCM, who also carried a variant of uncertain significance in the MYH7 gene (Serio 2009). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). A different variant occurring at the same codon, p.Arg597Gln, is a well documented pathogenic mutation (Clinvar variation ID: 164098), indicating that arginine at this position is important for MYBPC3 protein function. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -

Cardiovascular phenotype Uncertain:2
Sep 25, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.R597W variant (also known as c.1789C>T), located in coding exon 18 of the MYBPC3 gene, results from a C to T substitution at nucleotide position 1789. The arginine at codon 597 is replaced by tryptophan, an amino acid with dissimilar properties. This variant was reported in a compound heterozygous individual with hypertrophic cardiomyopathy (HCM), who had an MYBPC3 frameshift variant in trans, and was also reported in two unaffected relatives, who were heterozygous for R597W only (Chen X et al. Medicine (Baltimore), 2019 Mar;98:e14676). In addition, this alteration has been reported in HCM cohorts; however, limited clinical information was provided (Coppini R et al. J. Am. Coll. Cardiol., 2014 Dec;64:2589-2600; Walsh R et al. Genet. Med., 2017 Feb;19:192-203). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PM2, PS4_supp, PP3 -

Cardiomyopathy Uncertain:1
Oct 23, 2023
Color Diagnostics, LLC DBA Color Health
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This missense variant replaces arginine with tryptophan at codon 597 of the MYBPC3 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant.This variant has been reported in two unrelated individuals affected with hypertrophic cardiomyopathy (HCM) (PMID: 25524337, 27532257). This variant has been reported in another individual affected with HCM, who also carried a pathogenic truncation variant in the same gene (PMID: 30896616). Additionally, this variant has been reported in three related individuals from an Italian family affected with HCM, who also carried a variant of uncertain significance in the MYH7 gene (Serio 2009). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). A different variant occurring at the same codon, p.Arg597Gln, is a well documented pathogenic mutation (Clinvar variation ID: 164098), indicating that arginine at this position is important for MYBPC3 protein function. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -

Hypertrophic cardiomyopathy 4;C3715165:Left ventricular noncompaction 10 Uncertain:1
Sep 30, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.41
CardioboostCm
Uncertain
0.84
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Uncertain
0.10
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.81
D;T;T
Eigen
Uncertain
0.67
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Pathogenic
0.99
D;D;D
M_CAP
Pathogenic
0.50
D
MetaRNN
Pathogenic
0.96
D;D;D
MetaSVM
Uncertain
0.10
D
MutationAssessor
Pathogenic
3.4
M;.;.
PhyloP100
3.7
PrimateAI
Uncertain
0.65
T
PROVEAN
Pathogenic
-6.8
D;.;D
REVEL
Pathogenic
0.84
Sift
Uncertain
0.0010
D;.;D
Sift4G
Pathogenic
0.0
D;D;D
Vest4
0.97
MVP
0.93
MPC
0.84
ClinPred
0.87
D
GERP RS
4.2
Varity_R
0.78
gMVP
0.86
Mutation Taster
=4/96
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.15
dbscSNV1_RF
Benign
0.53
SpliceAI score (max)
0.25
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.25
Position offset: 16

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201596087; hg19: chr11-47363543; API